GlassScriptPhysician profile
Biswas Joshi
NPI 1396079935
$1,096.22
in general payments reported to CMS, 2019-2025
13 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.31 · 2022: $107 · 2023: $194 · 2024: $382 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $204.21 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $172.65 | 2024-2025 | Tezspire, Fasenra |
| Regeneron Healthcare Solutions, INC. | $153.44 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $128.43 | 2023-2025 | Nucala |
| Pharming Healthcare, INC. | $84.10 | 2023-2025 | Joenja, Ruconest |
| Sanofi-Aventis U.S. LLC | $74.75 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.74 | 2024 | Takhzyro |
| Philips North America LLC | $54.55 | 2023-2025 | Respiratory |
| Biocryst US Sales Co., LLC | $41.22 | 2025 | Orladeyo |
| Sobi, INC | $40.83 | 2022-2023 | |
| Octapharma USA, INC. | $40.70 | 2023 | Cutaquig |
| Hikma Pharmaceuticals USA | $19.98 | 2024 | Ryaltris |
| Ns Pharma, INC. | $19.62 | 2024 | Viltepso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Biswas Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.